கார்டிஃப் புற்றுநோயியல் விரிவாக்கப்பட்டது நுழைவு ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2021 News provided by Share this article SAN DIEGO, March 10, 2021 /PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced the publication of two abstracts that will be presented as electronic posters during Week 1 of the American Association for Cancer Research (AACR) Annual Meeting 2021, taking place virtually from April 10-15, 2021. Details on the electronic posters and corresponding abstracts are shown below. Title: Expanded access program of the PLK1 inhibitor onvansertib for treatment of patients with KRAS-mutant metastatic colorectal cancer

United statesDana farber cancer instituteDavid einsteinKatelyn caruso sharpeVicki kelemenJoyce allaireClinical outcomes researchCardiff oncology incHospital cancer centerBeth israel deaconess medical centerPrnewswire cardiff oncology incCardiff oncology expanded access programClinical research excluding trialsGenitourinary oncology programAmerican association for cancer researchLifesci communications